172 related articles for article (PubMed ID: 6644236)
1. Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogens.
Wakeling AE; Valcaccia B
J Endocrinol; 1983 Dec; 99(3):455-64. PubMed ID: 6644236
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the biological effects of tamoxifen and a new antioestrogen (LY 117018) on the immature rat uterus.
Wakeling AE; O'Connor KM; Newboult E
J Endocrinol; 1983 Dec; 99(3):447-53. PubMed ID: 6644235
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the metabolic activation of non-steroidal antioestrogens: a study of structure-activity relationships.
Allen KE; Clark ER; Jordan VC
Br J Pharmacol; 1980; 71(1):83-91. PubMed ID: 7470748
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal antioestrogens--receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells.
Wakeling AE; Valcaccia B; Newboult E; Green LR
J Steroid Biochem; 1984 Jan; 20(1):111-20. PubMed ID: 6538611
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of a novel oestrogen antagonist, ZK 119010, in rats and mice.
Nishino Y; Schneider MR; Michna H; von Angerer E
J Endocrinol; 1991 Sep; 130(3):409-14. PubMed ID: 1834757
[TBL] [Abstract][Full Text] [Related]
6. [The elucidation of the antiestrogen and antitumoral mechanisms of tamoxifen].
Borgna JL
Bull Cancer; 1994 Jan; 81(1):29-37. PubMed ID: 7949581
[TBL] [Abstract][Full Text] [Related]
7. Novel antioestrogens without partial agonist activity.
Wakeling AE; Bowler J
J Steroid Biochem; 1988 Oct; 31(4B):645-53. PubMed ID: 3199810
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl] [4-[2-(1-piperidinyl)ethoxy]-phenyl]methanone hydrochloride (LY156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity.
Jones CD; Jevnikar MG; Pike AJ; Peters MK; Black LJ; Thompson AR; Falcone JF; Clemens JA
J Med Chem; 1984 Aug; 27(8):1057-66. PubMed ID: 6431104
[TBL] [Abstract][Full Text] [Related]
9. Study of the in-vivo antioestrogenic action of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine HCl (DPPE), a novel intracellular histamine antagonist and antioestrogen binding site ligand.
Brandes LJ; Hogg GR
J Reprod Fertil; 1990 May; 89(1):59-67. PubMed ID: 2374133
[TBL] [Abstract][Full Text] [Related]
10. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.
Gottardis MM; Jordan VC
Cancer Res; 1987 Aug; 47(15):4020-4. PubMed ID: 3607747
[TBL] [Abstract][Full Text] [Related]
11. Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterus.
Jordan VC; Gosden B
Mol Cell Endocrinol; 1982 Aug; 27(3):291-306. PubMed ID: 7128917
[No Abstract] [Full Text] [Related]
12. A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity.
Jordan VC; Collins MM; Rowsby L; Prestwich G
J Endocrinol; 1977 Nov; 75(2):305-16. PubMed ID: 591813
[TBL] [Abstract][Full Text] [Related]
13. Antiestrogenic effects of LY 117018 in MCF-7 cells.
Scholl SM; Huff KK; Lippman ME
Endocrinology; 1983 Aug; 113(2):611-7. PubMed ID: 6872943
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
Jordan VC; Gosden B
Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937
[TBL] [Abstract][Full Text] [Related]
15. Biology and mode of action of pure antioestrogens.
Wakeling AE; Bowler J
J Steroid Biochem; 1988; 30(1-6):141-7. PubMed ID: 3386242
[TBL] [Abstract][Full Text] [Related]
16. Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer.
Suh N; Glasebrook AL; Palkowitz AD; Bryant HU; Burris LL; Starling JJ; Pearce HL; Williams C; Peer C; Wang Y; Sporn MB
Cancer Res; 2001 Dec; 61(23):8412-5. PubMed ID: 11731420
[TBL] [Abstract][Full Text] [Related]
17. Dose-related effects of non-steroidal antioestrogens nad oestrogens on the measurement of cytoplasmic oestrogen receptors in the rat and mouse uterus.
Jordan VC; Rowsby L; Dix CJ; Prestwich G
J Endocrinol; 1978 Jul; 78(1):71-81. PubMed ID: 681874
[TBL] [Abstract][Full Text] [Related]
18. Steroidal pure antioestrogens.
Wakeling AE; Bowler J
J Endocrinol; 1987 Mar; 112(3):R7-10. PubMed ID: 3559447
[TBL] [Abstract][Full Text] [Related]
19. Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice.
Black LJ; Goode RL
Life Sci; 1980 Apr; 26(17):1453-8. PubMed ID: 7382727
[No Abstract] [Full Text] [Related]
20. Activity of the antioestrogen trioxifene against N-Nitrosomethylurea-induced rat mammary carcinomas.
Rose DP; Fischer AH; Jordan VC
Eur J Cancer Clin Oncol; 1981 Aug; 17(8):893-8. PubMed ID: 7198978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
